DEVELOPING NOVEL THERAPIES FOR HR+/HER2- ADVANCED BREAST CANCER

Breast Cancer Survival Rates Survival rates for breast cancer vary based on factors like the stage at diagnosis, tumor subtype, and treatment options. The five-year survival rate for stage 2 breast cancer is around 90%, with slightly lower rates for stage 2B. Advances in HR+ HER2- breast cancer treatment continue to enhance patient outcomes, high